Status:
UNKNOWN
Mindfulness-based Intervention in COPD Dyads
Lead Sponsor:
Campus Bio-Medico University
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates the effectiveness of a Mindfulness-Based Stress Reduction intervention (MBSRI) on the reduction of stress, anxiety, and depression in people with COPD and their family caregivers....
Detailed Description
People affected by Chronic Obstructive Pulmonary Disease (COPD) and their family caregivers (named dyads) often suffer from psychological distress, because of the physical problems and social isolatio...
Eligibility Criteria
Inclusion
- Persons able to read and understand Italian.
- people affected by COPD stage C (GOLD 3 o 4, and/or 2 or more exacerbations per year or 1 or more hospitalizations for exacerbations and score of COPD assessment test-CAT \< 10 or mMRC 0-1).
- People affected by COPD stage D (GOLD 3 o 4, and/or 2 or more exacerbations per year or 1 or more hospitalizations for exacerbations and score of COPD assessment test-CAT ≥ 10 or mMRC ≥ 2).
Exclusion
- Persons or dyads not able to guarantee the presence on the MBSR intervention sessions for the four months requested.
- Persons with diagnosis of anxiety or depression.
- Persons that have practiced before or actually practice yoga or mindfulness.
- Persons with cognitive impairment.
- Persons under continuous oxygen therapy.
- Persons with diagnosis of cancer or other terminal diseases or any psychiatric problem.
Key Trial Info
Start Date :
April 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04898972
Start Date
April 20 2021
End Date
December 30 2023
Last Update
August 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Campus Bio-medico University of Rome
Rome, Italy, 00121